Merit Medical Systems, Inc. (MMSI) Shares Sold by Great West Life Assurance Co. Can

Great West Life Assurance Co. Can lessened its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 6.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 68,463 shares of the medical instruments supplier’s stock after selling 4,393 shares during the period. Great West Life Assurance Co. Can owned about 0.14% of Merit Medical Systems worth $2,879,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Advisors Asset Management Inc. lifted its holdings in shares of Merit Medical Systems by 28.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock worth $142,000 after purchasing an additional 820 shares during the last quarter. Ameritas Investment Partners Inc. lifted its holdings in shares of Merit Medical Systems by 20.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after purchasing an additional 738 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Merit Medical Systems in the 3rd quarter worth approximately $189,000. Riverhead Capital Management LLC lifted its holdings in shares of Merit Medical Systems by 67.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock worth $198,000 after purchasing an additional 2,098 shares during the last quarter. Finally, Flinton Capital Management LLC lifted its holdings in shares of Merit Medical Systems by 67.4% in the 2nd quarter. Flinton Capital Management LLC now owns 5,236 shares of the medical instruments supplier’s stock worth $200,000 after purchasing an additional 2,108 shares during the last quarter. 90.89% of the stock is currently owned by institutional investors.

In related news, Director Kent W. Stanger sold 2,918 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $44.55, for a total value of $129,996.90. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 5.00% of the stock is owned by company insiders.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at $43.65 on Wednesday. Merit Medical Systems, Inc. has a 1 year low of $24.23 and a 1 year high of $45.50. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43. The company has a market capitalization of $2,176.12, a P/E ratio of 34.13, a P/E/G ratio of 2.94 and a beta of 1.23.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, beating the consensus estimate of $0.30 by $0.02. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The firm had revenue of $179.30 million for the quarter, compared to analysts’ expectations of $181.28 million. During the same period last year, the firm earned $0.26 EPS. The firm’s revenue was up 14.2% compared to the same quarter last year. equities analysts anticipate that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current year.

MMSI has been the topic of several recent research reports. Canaccord Genuity reissued a “buy” rating and issued a $45.00 price target on shares of Merit Medical Systems in a report on Wednesday, September 6th. ValuEngine raised Merit Medical Systems from a “hold” rating to a “buy” rating in a report on Tuesday, November 21st. SunTrust Banks set a $47.00 price target on Merit Medical Systems and gave the stock a “buy” rating in a report on Thursday, November 16th. Zacks Investment Research raised Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 price target on the stock in a report on Saturday, October 28th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $44.00 price target on shares of Merit Medical Systems in a report on Monday, August 28th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $43.77.

COPYRIGHT VIOLATION WARNING: This article was first reported by Week Herald and is the property of of Week Herald. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://weekherald.com/2017/12/13/merit-medical-systems-inc-mmsi-shares-sold-by-great-west-life-assurance-co-can.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply